Niklas Pallmann

Papers

Total Citations

H-Index

About

Niklas Pallmann is at the forefront of merging robotics with tissue engineering, pioneering automated platforms for biological production. His key research areas include robotic-enabled biological automation, 3D tissue engineering, and the development of animal-free testing alternatives. Pallmann’s major contribution, the ReBiA (Robotic Enabled Biological Automation) system, represents a breakthrough in scalable 3D epithelial tissue production, directly addressing the global shift away from animal testing mandated by regulatory bodies like the FDA and the European Parliament. His work, notably the 2024 paper "ReBiA—Robotic Enabled Biological Automation: 3D Epithelial Tissue Production," has already garnered 13 citations, signaling its immediate impact on the field. By integrating robotics with cell culture, Pallmann is not only advancing high-throughput tissue fabrication but also aligning with ethical and regulatory trends toward animal-free research. His achievements position him as a key innovator in the transition to more humane, automated, and reproducible biological manufacturing, offering a tangible solution for pharmaceutical testing and regenerative medicine.